Guardant Health Inc annual free cash flow for fiscal TTM was -$229 million, an increase of 1.7% from -$233 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($229M) | ($233M) | ($275M) | ($345M) | ($387M) | ($284M) | ($158M) | ($68M) | ($92M) | ($81M) | ($38M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | ($70M) | ($71M) | ($42M) | ($46M) | ($66M) | ($67M) | ($83M) | ($55M) | ($99M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More GH metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All GH financial statements → Interactive GH charts →
About TickerBase · Data methodology & sources · Privacy · Terms